Home > Drug Search >
  • company_query: Aphton Corporation
  •   > 
Drug Filter
Category:
chemistry (2) biology (20)
Status:
Approved (1) BLA Filing (1) Phase Ⅲ (7) Phase Ⅱ (12) Phase Ⅰ (1)
Clinical Stage:
Pending (3) Active (12) Discontinued (6)
Bio-Type:
Gene therapy (1) Vaccine (15) Recombinant cytokines (1) Recombinant hormone (1) Fusion protein (2)
Indication:
Allergic rhinoconjunctivitis (1) Alzheimer's disease (AD) (1) Bladder cancer (1) Breast cancer (2) ischaemic heart disorder (1) Coronary artery disease (CAD) (1) Delayed graft function (1) Eczema (1) Gastric cancer (1) Influenza virus infection (1) Melanoma (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Osteoporosis (1) Pancreatic cancer (1) Peripheral arterial disease (PAD) (1) Measles (1) Mumps (1) Rubella (1) Prostate cancer (2) Urinary tract infections (1) Reperfusion injury (1) Colorectal cancer (3) Campylobacter infections (1) neurodermatitis (1) Helicobacter pylori infection (1) Skin pruritus (1) Glioblastoma (1) Ebola virus disease (EVD) (1) Inflammation (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top